Anti-inflammatory drugs in rheumatic diseases.
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000962:Antimalarials / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001241:Aspirin / Q000627:therapeutic use; D004347:Drug Interactions; D005439:Flufenamic Acid / Q000627:therapeutic use; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007213:Indomethacin / Q000009:adverse effects / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008528:Mefenamic Acid / Q000627:therapeutic use; D010003:Osteoarthritis / Q000188:drug therapy; D010113:Oxyphenbutazone / Q000627:therapeutic use; D010653:Phenylbutazone / Q000009:adverse effects / Q000627:therapeutic use; D011111:Polymyalgia Rheumatica / Q000188:drug therapy; D011239:Prednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011565:Psoriasis / Q000188:drug therapy; D012216:Rheumatic Diseases / Q000188:drug therapy*; D013167:Spondylitis, Ankylosing / Q000188:drug therapy; D013276:Stomach Ulcer / Q000139:chemically induced
D000893:Anti-Inflammatory Agents; D000962:Antimalarials; D007166:Immunosuppressive Agents; D008528:Mefenamic Acid; D005439:Flufenamic Acid; D006046:Gold; D000324:Adrenocorticotropic Hormone; D011239:Prednisolone; D010653:Phenylbutazone; D010113:Oxyphenbutazone; D001241:Aspirin; D011241:Prednisone; D007213:Indomethacin